(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DGAT2 mRNA] CTD PMID:31150632 (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in increased expression of DGAT2 mRNA] CTD PMID:22464149 1,2-dimethylhydrazine affects expression ISO RGD:1551902 6480464 1, 2-Dimethylhydrazine affects the expression of DGAT2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1551902 6480464 Ethinyl Estradiol promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of DGAT2 mRNA] CTD PMID:24440342 17beta-estradiol decreases expression ISO RGD:1352737 6480464 Estradiol results in decreased expression of DGAT2 mRNA CTD PMID:20106945 17beta-estradiol decreases expression ISO RGD:1551902 6480464 Estradiol results in decreased expression of DGAT2 mRNA CTD PMID:19484750 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:1352737 6480464 Dihydrotestosterone results in decreased expression of DGAT2 mRNA CTD PMID:18801408 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1551902 6480464 [Tetrachlorodibenzodioxin co-treated with bisphenol A co-treated with 2 more ... CTD PMID:23756648 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:21394737 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1551902 6480464 2 more ... CTD PMID:29523931 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551902 6480464 [Tetrachlorodibenzodioxin co-treated with bisphenol A co-treated with 2 more ... CTD PMID:21846477 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551902 6480464 Tetrachlorodibenzodioxin affects the expression of DGAT2 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1352737 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DGAT2 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551902 6480464 Tetrachlorodibenzodioxin results in decreased expression of DGAT2 mRNA CTD PMID:21846477 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551902 6480464 Tetrachlorodibenzodioxin results in increased expression of DGAT2 mRNA CTD PMID:22539624 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352737 6480464 Tetrachlorodibenzodioxin results in decreased expression of DGAT2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DGAT2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DGAT2 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of DGAT2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of DGAT2 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:26693162 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1551902 6480464 [3 more ... CTD PMID:28973532 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1551902 6480464 3 more ... CTD PMID:19467301 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1551902 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of DGAT2 mRNA CTD PMID:23428407 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352737 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DGAT2 mRNA more ... CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:1551902 6480464 4, 4'-diaminodiphenylmethane results in increased expression of DGAT2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:1352737 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of DGAT2 mRNA CTD PMID:30616060 4-hydroxyphenyl retinamide decreases expression ISO RGD:1551902 6480464 Fenretinide results in decreased expression of DGAT2 mRNA CTD PMID:28973697 5-(2-chloroethyl)-4-methylthiazole multiple interactions ISO RGD:1551902 6480464 Chlormethiazole promotes the reaction [Ethanol results in increased expression of DGAT2 protein] CTD PMID:24892905 8-Br-cAMP decreases expression ISO RGD:1352737 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DGAT2 mRNA CTD PMID:22079614 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of DGAT2 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1352737 6480464 Aflatoxin B1 affects the expression of DGAT2 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1352737 6480464 Aflatoxin B1 results in decreased expression of DGAT2 mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1551902 6480464 Aflatoxin B1 results in decreased expression of DGAT2 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:1352737 6480464 Tretinoin results in decreased expression of DGAT2 mRNA CTD PMID:23724009 amiodarone decreases expression ISO RGD:1551902 6480464 Amiodarone results in decreased expression of DGAT2 mRNA CTD PMID:28962527 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DGAT2 mRNA CTD PMID:16483693 atrazine multiple interactions ISO RGD:1551902 6480464 Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of DGAT2 mRNA] CTD PMID:24440342 avobenzone decreases expression ISO RGD:1352737 6480464 avobenzone results in decreased expression of DGAT2 mRNA CTD PMID:31016361 benzene increases expression ISO RGD:1352737 6480464 Benzene results in increased expression of DGAT2 mRNA CTD PMID:19162166 benzene-1,2,4-triol multiple interactions ISO RGD:1352737 6480464 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in decreased expression of DGAT2 mRNA] CTD PMID:24530881 benzene-1,2,4-triol decreases expression ISO RGD:1352737 6480464 hydroxyhydroquinone results in decreased expression of DGAT2 mRNA CTD PMID:24530881 benzo[a]pyrene decreases expression ISO RGD:1352737 6480464 Benzo(a)pyrene results in decreased expression of DGAT2 mRNA CTD PMID:19737606 , PMID:32234424 benzo[a]pyrene multiple interactions ISO RGD:1551902 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA CTD PMID:27858113 benzo[b]fluoranthene multiple interactions ISO RGD:1551902 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA CTD PMID:27858113 benzylpenicillin multiple interactions ISO RGD:1551902 6480464 [Penicillin G co-treated with Erythromycin] results in increased expression of DGAT2 mRNA CTD PMID:27503388 beta-naphthoflavone decreases expression ISO RGD:1352737 6480464 beta-Naphthoflavone results in decreased expression of DGAT2 mRNA CTD PMID:19737606 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1551902 6480464 [Tetrachlorodibenzodioxin co-treated with bisphenol A co-treated with 2 more ... CTD PMID:23756648 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1352737 6480464 Diethylhexyl Phthalate results in decreased expression of DGAT2 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1352737 6480464 bisphenol A results in decreased expression of DGAT2 mRNA CTD PMID:22576693 bisphenol A affects expression ISO RGD:1352737 6480464 bisphenol A affects the expression of DGAT2 mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DGAT2 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1352737 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DGAT2 mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:1551902 6480464 bisphenol A results in increased expression of DGAT2 mRNA CTD PMID:25594700 bisphenol A multiple interactions ISO RGD:1551902 6480464 [Tetrachlorodibenzodioxin co-treated with bisphenol A co-treated with 2 more ... CTD PMID:23756648 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DGAT2 mRNA CTD PMID:24988533 bisphenol A increases methylation ISO RGD:1352737 6480464 bisphenol A results in increased methylation of DGAT2 gene CTD PMID:22576693 bisphenol F multiple interactions ISO RGD:1352737 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of DGAT2 mRNA CTD PMID:28628672 cadmium dichloride increases expression ISO RGD:1551902 6480464 Cadmium Chloride results in increased expression of DGAT2 mRNA CTD PMID:26352046 calcitriol increases expression ISO RGD:1352737 6480464 Calcitriol results in increased expression of DGAT2 mRNA CTD PMID:16002434 carbendazim increases expression ISO RGD:1551902 6480464 carbendazim results in increased expression of DGAT2 mRNA CTD PMID:26071454 carbon nanotube increases expression ISO RGD:1551902 6480464 Nanotubes, Carbon analog results in increased expression of DGAT2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1551902 6480464 Nanotubes, Carbon results in decreased expression of DGAT2 mRNA CTD PMID:25554681 , PMID:25620056 cholesterol multiple interactions ISO RGD:1551902 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of DGAT2 mRNA more ... CTD PMID:24440342 choline multiple interactions ISO RGD:1551902 6480464 [3 more ... CTD PMID:25178843 more ... chrysene increases expression ISO RGD:1551902 6480464 chrysene results in increased expression of DGAT2 mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:1551902 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA CTD PMID:27858113 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of DGAT2 mRNA CTD PMID:12851107 clofibrate decreases expression ISO RGD:1551902 6480464 Clofibrate results in decreased expression of DGAT2 mRNA CTD PMID:23811191 copper(II) sulfate decreases expression ISO RGD:1352737 6480464 Copper Sulfate results in decreased expression of DGAT2 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1551902 6480464 Cyclosporine results in increased expression of DGAT2 mRNA CTD PMID:25224403 cyclosporin A increases expression ISO RGD:1352737 6480464 Cyclosporine results in increased expression of DGAT2 mRNA CTD PMID:28903485 cyclosporin A decreases expression ISO RGD:1352737 6480464 Cyclosporine results in decreased expression of DGAT2 mRNA CTD PMID:20106945 more ... cyclosporin A decreases expression ISO RGD:1551902 6480464 Cyclosporine results in decreased expression of DGAT2 mRNA CTD PMID:23830897 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of DGAT2 mRNA CTD PMID:20032058 dexamethasone increases expression ISO RGD:1551902 6480464 Dexamethasone results in increased expression of DGAT2 mRNA CTD PMID:31053639 dexamethasone multiple interactions ISO RGD:1352737 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DGAT2 mRNA more ... CTD PMID:28628672 dexamethasone increases expression ISO RGD:1352737 6480464 Dexamethasone results in increased expression of DGAT2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1551902 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of DGAT2 mRNA CTD PMID:23428407 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of DGAT2 mRNA] CTD PMID:20032058 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA] CTD PMID:24146112 dioscin multiple interactions ISO RGD:1551902 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA] CTD PMID:24146112 diuron increases expression EXP 6480464 Diuron results in increased expression of DGAT2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [mangiferin results in increased expression of DGAT2 protein] CTD PMID:22292039 endosulfan multiple interactions ISO RGD:1352737 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DGAT2 mRNA CTD PMID:26159488 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of DGAT2 mRNA CTD PMID:29391264 erythromycin A multiple interactions ISO RGD:1551902 6480464 [Penicillin G co-treated with Erythromycin] results in increased expression of DGAT2 mRNA CTD PMID:27503388 ethanol multiple interactions ISO RGD:1551902 6480464 [ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of DGAT2 mRNA more ... CTD PMID:20637825 more ... ethanol affects expression ISO RGD:1551902 6480464 Ethanol affects the expression of DGAT2 mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA] CTD PMID:24146112 ethanol increases expression ISO RGD:1551902 6480464 Ethanol results in increased expression of DGAT2 mRNA, Ethanol results in increased expression of DGAT2 protein CTD PMID:18620774 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of DGAT2 mRNA CTD PMID:24146112 ethanol multiple interactions ISO RGD:1352737 6480464 PER1 protein promotes the reaction [Ethanol results in increased expression of DGAT2 mRNA] CTD PMID:24144995 ethanol increases expression ISO RGD:1352737 6480464 Ethanol results in increased expression of DGAT2 mRNA CTD PMID:24144995 farnesol multiple interactions ISO RGD:1352737 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of DGAT2 mRNA CTD PMID:30611723 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DGAT2 mRNA CTD PMID:21525395 , PMID:24793618 fructose multiple interactions ISO RGD:1551902 6480464 [FGF21 gene mutant form results in increased susceptibility to Fructose] which results in decreased expression of DGAT2 mRNA CTD PMID:28123933 genistein increases expression ISO RGD:1352737 6480464 Genistein results in increased expression of DGAT2 mRNA CTD PMID:20884965 graphite increases expression ISO RGD:1551902 6480464 Graphite results in increased expression of DGAT2 mRNA CTD PMID:27440207 GW 4064 decreases expression ISO RGD:1352737 6480464 GW 4064 results in decreased expression of DGAT2 mRNA CTD PMID:30611723 GW 4064 multiple interactions ISO RGD:1352737 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of DGAT2 mRNA CTD PMID:30611723 GW 7647 increases expression ISO RGD:1352737 6480464 GW 7647 results in increased expression of DGAT2 mRNA CTD PMID:30611723 hydrogen peroxide affects expression ISO RGD:1352737 6480464 Hydrogen Peroxide affects the expression of DGAT2 mRNA CTD PMID:23410634 hydrogen peroxide increases expression ISO RGD:1352737 6480464 Hydrogen Peroxide results in increased expression of DGAT2 mRNA CTD PMID:29317476 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1551902 6480464 indeno(1 more ... CTD PMID:26377693 indometacin multiple interactions ISO RGD:1352737 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DGAT2 mRNA more ... CTD PMID:28628672 ketamine increases expression EXP 6480464 Ketamine results in increased expression of DGAT2 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:1551902 6480464 [3 more ... CTD PMID:25178843 more ... L-methionine decreases expression ISO RGD:1551902 6480464 Methionine deficiency results in decreased expression of DGAT2 mRNA CTD PMID:25178843 lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in increased expression of DGAT2 mRNA] CTD PMID:22464149 mangiferin affects expression EXP 6480464 mangiferin affects the expression of DGAT2 mRNA, mangiferin affects the expression of DGAT2 protein CTD PMID:25123789 mangiferin decreases expression EXP 6480464 mangiferin results in decreased expression of DGAT2 protein CTD PMID:22292039 mangiferin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [mangiferin results in increased expression of DGAT2 protein] CTD PMID:22292039 menadione affects expression ISO RGD:1352737 6480464 Vitamin K 3 affects the expression of DGAT2 mRNA CTD PMID:20044591 , PMID:23410634 methotrexate increases expression ISO RGD:1352737 6480464 Methotrexate results in increased expression of DGAT2 mRNA CTD PMID:17400583 methyl methanesulfonate decreases expression ISO RGD:1352737 6480464 Methyl Methanesulfonate results in decreased expression of DGAT2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1352737 6480464 methylmercuric chloride results in decreased expression of DGAT2 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases expression ISO RGD:1551902 6480464 1-Methyl-4-phenylpyridinium results in increased expression of DGAT2 mRNA CTD PMID:22776087 nickel atom decreases expression ISO RGD:1352737 6480464 Nickel results in decreased expression of DGAT2 mRNA CTD PMID:24768652 , PMID:25583101 nicotinic acid multiple interactions ISO RGD:1352737 6480464 [Niacin results in decreased activity of DGAT2 protein] which results in decreased chemical synthesis of Triglycerides CTD PMID:15258194 nicotinic acid decreases activity ISO RGD:1352737 6480464 Niacin results in decreased activity of DGAT2 protein CTD PMID:15258194 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of DGAT2 mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:1352737 6480464 methyleugenol results in decreased expression of DGAT2 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO RGD:1352737 6480464 obeticholic acid results in decreased expression of DGAT2 mRNA CTD PMID:27939613 oleic acid multiple interactions ISO RGD:1352737 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of DGAT2 mRNA, [GW 4064 co-treated with Oleic Acid] results in decreased expression of DGAT2 mRNA CTD PMID:30611723 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of DGAT2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DGAT2 mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of DGAT2 mRNA CTD PMID:17984051 paracetamol decreases expression ISO RGD:1352737 6480464 Acetaminophen results in decreased expression of DGAT2 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression ISO RGD:1551902 6480464 Acetaminophen affects the expression of DGAT2 mRNA CTD PMID:17562736 perfluorohexanesulfonic acid decreases expression ISO RGD:1551902 6480464 perfluorohexanesulfonic acid results in decreased expression of DGAT2 mRNA CTD PMID:21705711 perfluorononanoic acid decreases expression ISO RGD:1352737 6480464 perfluorononanoic acid results in decreased expression of DGAT2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1551902 6480464 perfluorooctane sulfonic acid results in decreased expression of DGAT2 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1352737 6480464 perfluorooctane sulfonic acid results in decreased expression of DGAT2 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO RGD:1551902 6480464 perfluorooctanoic acid results in decreased expression of DGAT2 mRNA CTD PMID:21499893 , PMID:30657992 pioglitazone increases expression ISO RGD:1551902 6480464 pioglitazone results in increased expression of DGAT2 mRNA CTD PMID:20723549 pirinixic acid multiple interactions ISO RGD:1352737 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DGAT2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1551902 6480464 pirinixic acid results in decreased expression of DGAT2 mRNA CTD PMID:23811191 pirinixic acid increases expression ISO RGD:1551902 6480464 pirinixic acid results in increased expression of DGAT2 mRNA CTD PMID:17426115 potassium dichromate increases expression ISO RGD:1551902 6480464 Potassium Dichromate results in increased expression of DGAT2 mRNA CTD PMID:23608068 propamocarb decreases expression ISO RGD:1551902 6480464 propamocarb results in decreased expression of DGAT2 mRNA CTD PMID:29137890 propiconazole decreases expression ISO RGD:1551902 6480464 propiconazole results in decreased expression of DGAT2 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1352737 6480464 Quercetin results in decreased expression of DGAT2 mRNA CTD PMID:21632981 rebaudioside A multiple interactions ISO RGD:1551902 6480464 rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA] CTD PMID:25554529 rifaximin multiple interactions ISO RGD:1352737 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of DGAT2 mRNA CTD PMID:22790967 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases expression EXP 6480464 Buthionine Sulfoximine results in decreased expression of DGAT2 mRNA CTD PMID:20482862 silicon dioxide increases expression ISO RGD:1551902 6480464 Silicon Dioxide results in increased expression of DGAT2 mRNA CTD PMID:23221170 sodium arsenite decreases expression ISO RGD:1551902 6480464 sodium arsenite results in decreased expression of DGAT2 mRNA CTD PMID:25155036 sodium arsenite decreases expression ISO RGD:1352737 6480464 sodium arsenite results in decreased expression of DGAT2 mRNA CTD PMID:29301061 steviol multiple interactions ISO RGD:1551902 6480464 steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA] CTD PMID:25554529 stevioside multiple interactions ISO RGD:1551902 6480464 stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of DGAT2 mRNA] CTD PMID:25554529 sucrose multiple interactions ISO RGD:1551902 6480464 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of DGAT2 mRNA more ... CTD PMID:24440342 sulforaphane increases expression ISO RGD:1551902 6480464 sulforafan results in increased expression of DGAT2 mRNA CTD PMID:30529165 tamoxifen decreases expression ISO RGD:1551902 6480464 Tamoxifen results in decreased expression of DGAT2 mRNA CTD PMID:23038002 tectoridin multiple interactions ISO RGD:1551902 6480464 tectoridin inhibits the reaction [Ethanol results in increased expression of DGAT2 mRNA] CTD PMID:20637825 tert-butyl hydroperoxide affects expression ISO RGD:1352737 6480464 tert-Butylhydroperoxide affects the expression of DGAT2 mRNA CTD PMID:23410634 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of DGAT2 mRNA] CTD PMID:20032058 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DGAT2 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of DGAT2 mRNA CTD PMID:31150632 tetracycline increases expression ISO RGD:1352737 6480464 Tetracycline results in increased expression of DGAT2 protein CTD PMID:25745068 tetracycline multiple interactions ISO RGD:1352737 6480464 Tetracycline promotes the reaction [DGAT2 protein results in increased chemical synthesis of Triglycerides] CTD PMID:25745068 tetracycline increases expression ISO RGD:1551902 6480464 Tetracycline results in increased expression of DGAT2 mRNA, Tetracycline results in increased expression of DGAT2 protein CTD PMID:25745068 tetraphene multiple interactions ISO RGD:1551902 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DGAT2 mRNA CTD PMID:27858113 titanium dioxide decreases expression ISO RGD:1551902 6480464 titanium dioxide results in decreased expression of DGAT2 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of DGAT2 mRNA CTD PMID:25729387 tributyl phosphate increases expression ISO RGD:1352737 6480464 tributyl phosphate results in increased expression of DGAT2 mRNA CTD PMID:30966736 tributylstannane increases expression ISO RGD:1551902 6480464 tributyltin results in increased expression of DGAT2 mRNA CTD PMID:23428407 trichloroethene multiple interactions ISO RGD:1551902 6480464 PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of DGAT2 mRNA] CTD PMID:20709644 trichloroethene increases expression ISO RGD:1551902 6480464 Trichloroethylene results in increased expression of DGAT2 mRNA CTD PMID:19254012 , PMID:20709644 trichostatin A decreases expression ISO RGD:1352737 6480464 trichostatin A results in decreased expression of DGAT2 mRNA CTD PMID:24935251 triclosan affects expression ISO RGD:1352737 6480464 Triclosan affects the expression of DGAT2 mRNA CTD PMID:31714634 triclosan decreases expression ISO RGD:1352737 6480464 Triclosan results in decreased expression of DGAT2 mRNA CTD PMID:30510588 triphenyl phosphate increases expression ISO RGD:1352737 6480464 triphenyl phosphate results in increased expression of DGAT2 mRNA CTD PMID:30966736 Tris(2,3-dibromopropyl) phosphate increases expression ISO RGD:1352737 6480464 tris(2, 3-dibromopropyl)phosphate results in increased expression of DGAT2 mRNA CTD PMID:30966736 tris(2-butoxyethyl) phosphate increases expression ISO RGD:1352737 6480464 tris(2-butoxyethyl) phosphate results in increased expression of DGAT2 mRNA CTD PMID:30966736 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of DGAT2 mRNA CTD PMID:24136188 urethane decreases expression ISO RGD:1352737 6480464 Urethane results in decreased expression of DGAT2 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of DGAT2 mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:1551902 6480464 Valproic Acid affects the expression of DGAT2 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid affects expression ISO RGD:1352737 6480464 Valproic Acid affects the expression of DGAT2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1352737 6480464 Valproic Acid results in increased expression of DGAT2 mRNA CTD PMID:23179753 , PMID:25716160 vancomycin increases expression ISO RGD:1551902 6480464 Vancomycin results in increased expression of DGAT2 mRNA CTD PMID:18930951
Gene-Chemical Interaction Annotations
